Department of Radiological Technology, National Cancer Center Hospital East, Kashiwa, Japan.
J Appl Clin Med Phys. 2023 Dec;24(12):e14125. doi: 10.1002/acm2.14125. Epub 2023 Aug 21.
Volumetric modulated arc therapy (VMAT) with cisplatin for head and neck cancer is often accompanied by symptoms of pharyngeal and oral mucositis. However, no standard medical program exists for the prevention and treatment of mucositis, and the mechanisms of mucositis have not yet been fully proven. Therefore, adaptive radiotherapy (ART), which is a re-planning process, is administered when severe mucositis develops during the treatment period. We extracted the treatment plans of patients who developed severe mucositis from DICOM data and used machine learning to determine its quantitative features. This study aimed to develop a machine learning program that can predict the development of mucositis requiring ART. This study included 61 patients who received concurrent chemotherapy and radiotherapy (RT). For each patient, the equivalent square field size of each segmental irradiation field used for VMAT, dose per segment (Gy), clinical target volume high, and mean dose of the oral cavity (Gy) were calculated. Furthermore, 671 five-dimensional lists were generated from the acquired data. Support vector machine (SVM) and K-nearest neighbor (KNN) were used for machine learning. For the accuracy score, the test size was varied from 10% to 90%, and the random number of data extracted in each test size was further varied from 1 to 100 to calculate a mean accuracy score. The mean accuracy scores of SVM and KNN were 0.981 ± 0.020 and 0.972 ± 0.033, respectively. The presence or absence of ART for mucositis was classified with high accuracy. The classification of the five-dimensional list was implemented with high accuracy, and a program was constructed to predict the onset of mucositis requiring ART before treatment began. This study suggests that it may support preventive measures against mucositis and the completion of RT without having to re-plan.
容积旋转调强放疗(VMAT)联合顺铂治疗头颈部癌症常伴有咽和口腔黏膜炎症状。然而,目前尚无预防和治疗黏膜炎的标准医疗方案,且黏膜炎的发病机制尚未得到充分证实。因此,当治疗过程中出现严重黏膜炎时,会进行适应性放疗(ART),这是一种重新计划的过程。我们从 DICOM 数据中提取发生严重黏膜炎的患者的治疗计划,并使用机器学习来确定其定量特征。本研究旨在开发一种可以预测需要 ART 的黏膜炎发展的机器学习程序。本研究纳入了 61 例接受同期化疗和放疗(RT)的患者。对于每位患者,计算用于 VMAT 的每个节段性照射野的等效平方野大小、每个节段的剂量(Gy)、临床靶区高剂量和口腔平均剂量(Gy)。此外,从所获得的数据中生成了 671 个五维列表。支持向量机(SVM)和 K-最近邻(KNN)用于机器学习。对于准确率评分,测试大小从 10%变化到 90%,并且在每个测试大小中进一步从 1 变化到 100 次提取数据的随机数量,以计算平均准确率评分。SVM 和 KNN 的平均准确率评分为 0.981±0.020 和 0.972±0.033。黏膜炎 ART 的有无分类具有很高的准确率。五维列表的分类具有很高的准确率,并构建了一个程序,以便在治疗开始前预测需要 ART 的黏膜炎的发生。本研究表明,它可能支持预防黏膜炎和无需重新计划即可完成 RT 的措施。